申联生物2025年净利亏损1909.07万元，同比减亏

Core Viewpoint - The company reported a revenue of approximately 288 million yuan for the fiscal year 2025, reflecting a year-on-year decline of 4.99%, while achieving a reduction in net loss to 19.09 million yuan [2] Group 1: Financial Performance - The company's revenue for 2025 was about 288 million yuan, down 4.99% compared to the previous year [2] - The net profit attributable to the company was a loss of 19.09 million yuan, indicating a reduction in losses year-on-year [2] Group 2: Operational Insights - The reduction in losses was primarily due to impairment provisions made for ongoing projects in 2024 [2] - Despite intense competition in the industry, the company made positive progress in product and marketing efforts [2] - The company implemented more precise and effective cost control measures [2]